Cargando…
Induced Fetal Human Muscle Stem Cells with High Therapeutic Potential in a Mouse Muscular Dystrophy Model
Duchenne muscular dystrophy (DMD) is a progressive and fatal muscle-wasting disease caused by DYSTROPHIN deficiency. Cell therapy using muscle stem cells (MuSCs) is a potential cure. Here, we report a differentiation method to generate fetal MuSCs from human induced pluripotent stem cells (iPSCs) by...
Autores principales: | Zhao, Mingming, Tazumi, Atsutoshi, Takayama, Satoru, Takenaka-Ninagawa, Nana, Nalbandian, Minas, Nagai, Miki, Nakamura, Yumi, Nakasa, Masanori, Watanabe, Akira, Ikeya, Makoto, Hotta, Akitsu, Ito, Yuta, Sato, Takahiko, Sakurai, Hidetoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363940/ https://www.ncbi.nlm.nih.gov/pubmed/32619494 http://dx.doi.org/10.1016/j.stemcr.2020.06.004 |
Ejemplares similares
-
Collagen-VI supplementation by cell transplantation improves muscle regeneration in Ullrich congenital muscular dystrophy model mice
por: Takenaka-Ninagawa, Nana, et al.
Publicado: (2021) -
Genome Editing Gene Therapy for Duchenne Muscular Dystrophy
por: Hotta, Akitsu
Publicado: (2015) -
A muscle fatigue-like contractile decline was recapitulated using skeletal myotubes from Duchenne muscular dystrophy patient-derived iPSCs
por: Uchimura, Tomoya, et al.
Publicado: (2021) -
Human Skeletal Muscle Cells Derived from the Orbicularis Oculi Have Regenerative Capacity for Duchenne Muscular Dystrophy
por: Yamanaka, Yukito, et al.
Publicado: (2019) -
Characterization of hiPSC-Derived Muscle Progenitors Reveals Distinctive Markers for Myogenic Cell Purification Toward Cell Therapy
por: Nalbandian, Minas, et al.
Publicado: (2021)